Prurisol abacavir acetate: Phase I started

Cellceutix began an open-label, crossover, U.S. Phase I bioequivalence trial to compare single doses of 50, 100 and 200 mg oral Prurisol vs. Ziagen abacavir sulfate in healthy volunteers. In 2012, FD...